Clinical chemistry · 2026
Association between Glycoprotein Acetylation-Indicated Inflammation and Small HDL Particle Number in Coronary Artery Disease.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Ivanova Anna A, Schieltz David M, Gardner Michael S, Parks Bryan A, Leszczynski Eric C, Sarzynski Mark A, Kraus Virginia B, Kraus William E, Kuklenyik Zsuzsanna, Barr John R
Аннотация
BACKGROUND: Glycoprotein acetylation (GlycA) is a nuclear magnetic resonance-derived biomarker of systemic inflammation. GlycA shows statistical interaction with small HDL particle number (s-HDL-P) in relation to coronary artery disease (CAD). This study examines the confounding effects of GlycA-related glycoproteins, hypertriglyceridemia, and s-HDL-P on CAD risk.
METHODS: Plasma samples from 752 participants in the CATHGEN biorepository were size-fractionated by asymmetric flow field-flow fractionation and analyzed by targeted proteomics and lipidomics. Fraction concentrations were converted to HDL particle number using a volumetric approach based on apolipoprotein A-I (APOA1) concentration, HDL size, and lipoprotein lipid composition. Correlations between GlycA, glycoproteins, total triglyceride (TG), HDL composition and HDL particle number, and their associations with CAD were assessed using multivariate least-squares fit and nominal logistic regression analysis, respectively.
RESULTS: Acute-phase inflammation-related glycoproteins (GlycA-proteins) correlated strongly with GlycA. However, the size-distribution profiles of GlycA-proteins were consistent with circulation as free dimers/trimers, and their lack of overlap with APOA1 profiles suggested no detectable HDL binding. In contrast, apolipoproteins and lipid transfer proteins showed size-profile shifts relative to APOA1 consistent with HDL binding. s-HDL-P showed an inverse association with GlycA, most significantly at low TG levels. In CAD models, significant GlycA × s-HDL-P interaction emerged only when TG was included as a covariate. CAD correlated with lipoprotein lipids, apolipoproteins, and lipid transfer proteins that influence lipoprotein remodeling.
CONCLUSIONS: GlycA-proteins circulate freely without direct HDL binding. The empirical GlycA × s-HDL-P interaction is consistent with indirect coupling between systemic inflammation and altered lipoprotein remodeling associated with CAD risk.
METHODS: Plasma samples from 752 participants in the CATHGEN biorepository were size-fractionated by asymmetric flow field-flow fractionation and analyzed by targeted proteomics and lipidomics. Fraction concentrations were converted to HDL particle number using a volumetric approach based on apolipoprotein A-I (APOA1) concentration, HDL size, and lipoprotein lipid composition. Correlations between GlycA, glycoproteins, total triglyceride (TG), HDL composition and HDL particle number, and their associations with CAD were assessed using multivariate least-squares fit and nominal logistic regression analysis, respectively.
RESULTS: Acute-phase inflammation-related glycoproteins (GlycA-proteins) correlated strongly with GlycA. However, the size-distribution profiles of GlycA-proteins were consistent with circulation as free dimers/trimers, and their lack of overlap with APOA1 profiles suggested no detectable HDL binding. In contrast, apolipoproteins and lipid transfer proteins showed size-profile shifts relative to APOA1 consistent with HDL binding. s-HDL-P showed an inverse association with GlycA, most significantly at low TG levels. In CAD models, significant GlycA × s-HDL-P interaction emerged only when TG was included as a covariate. CAD correlated with lipoprotein lipids, apolipoproteins, and lipid transfer proteins that influence lipoprotein remodeling.
CONCLUSIONS: GlycA-proteins circulate freely without direct HDL binding. The empirical GlycA × s-HDL-P interaction is consistent with indirect coupling between systemic inflammation and altered lipoprotein remodeling associated with CAD risk.